Hazel Yetişkin

Development of an Inactivated Vaccine against SARS CoV-2

Shaikh Terkıs Islam Pavel, Hazel Yetişkin, Muhammet Ali Uygut et al. · Vaccines · 2021 · 37 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in Nicotiana benthamiana Plant as a Vaccine Candidate against COVID-19

Tarlan Mamedov, Damla Yüksel, Merve Ilgın et al. · Vaccines · 2021 · 36 citations · Full text

Veterinary Medicine, Biotechnology, Infectious Diseases +17

Plant-Produced Glycosylated and In Vivo Deglycosylated Receptor Binding Domain Proteins of SARS-CoV-2 Induce Potent Neutralizing Responses in Mice

Tarlan Mamedov, Damla Yüksel, Merve Ilgın et al. · Viruses · 2021 · 32 citations · Full text

Life Sciences, Biotechnology, Immunology +16

Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model

Shaikh Terkıs Islam Pavel, Hazel Yetişkin, Ahmet Kalkan et al. · PLoS neglected tropical diseases · 2020 · 28 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials

Aykut Özdarendeli, Zafer Sezer, Shaikh Terkıs Islam Pavel et al. · Vaccine · 2022 · 25 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17